Loading clinical trials...
Loading clinical trials...
Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: Big Ten Cancer Research Consortium BTCRC-GU15-023
Conditions
Interventions
durvalumab
Radiation Therapy
Locations
7
United States
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Montefiore Medical Center
The Bronx, New York, United States
Penn State Cancer Intsitute
Hershey, Pennsylvania, United States
University of Wisconsin
Madison, Wisconsin, United States
Start Date
November 16, 2016
Primary Completion Date
August 6, 2019
Completion Date
April 27, 2022
Last Updated
November 27, 2024
NCT05489211
NCT07259226
NCT06820255
NCT04044859
NCT04180371
NCT06036121
Lead Sponsor
Monika Joshi, MD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions